Eli Lilly Lowers Cash Price for Zepbound Vials on Direct Sales Site
Eli Lilly lowers cash prices for Zepbound vials on its direct-to-consumer site, following recent White House agreements aimed at expanding U.S. access to GLP-1 therapies.
CNBC Top News
2 min read
Pharmaceuticals
Healthcare
Market News